HR 1424 increases the employer tax credit for providing paid family and medical leave under the Internal Revenue Code. It doubles the credit percentages - from 12.5% to 25% for smaller employers and 25% to 50% for larger employers - and makes the credit permanent by removing its temporary sunset provision. This bill directly affects employers who offer paid leave benefits, reducing their tax burden for providing such coverage. The changes apply to taxable years beginning after December 31, 2025.
HR 5915, the K2 Veterans Total Coverage Act of 2025, creates a presumption of service connection for specific health conditions in veterans who served at Karshi Khanabad Air Base (K2) in Uzbekistan. It amends U.S. Code to automatically link 15 categories of diseases - such as all cancers, thyroid disorders, bone diseases, cardiovascular issues, neurological conditions, and respiratory illnesses - to military service at that location. This means veterans diagnosed with any of these conditions no longer need to prove a direct connection between their illness and their K2 service to qualify for VA benefits. The bill directly affects veterans who were stationed at Karshi Khanabad Air Base, streamlining their access to healthcare and compensation.
The Preventing HEAT Illness and Deaths Act of 2025 establishes a National Integrated Heat Health Information System (NIHHIS) within NOAA to coordinate federal efforts on heat-related health risks. It creates an interagency committee to develop a strategic plan for improving data sharing, forecasting, and decision support tools for heat events, with a focus on communities disproportionately affected by extreme heat. The bill authorizes a Community Heat Resilience Program that provides grants to states, tribes, and local governments for projects like urban forestry, cooling centers, and heat action plans, requiring at least 40% of funds to target communities with environmental justice concerns. The legislation also mandates a study to identify gaps in heat information and response capabilities across the country. This comprehensive approach aims to reduce heat-related health impacts, particularly for vulnerable populations including older adults, outdoor workers, and communities of color.
HR 4964, the Child Interstate Abortion Notification Act, requires physicians performing abortions on minors traveling across state lines to provide 24 hours of actual or constructive notice to the minor's parent before the procedure. It directly affects minors (under 18) seeking abortions in a state different from their residence, their parents, and healthcare providers. Key provisions mandate parental notification unless exceptions apply - such as medical emergencies, court waivers, verified abuse disclosures, or the minor being accompanied by a documented parent. The law aims to ensure compliance with parental involvement requirements in the minor’s home state, with penalties for noncompliance including fines or imprisonment for physicians.
The VA National Formulary Act of 2025 creates a single, uniform list of drugs available at all VA medical facilities, replacing any local drug lists. It establishes a Pharmacy and Therapeutics Committee to make evidence-based decisions on drug inclusion (reviewing new FDA-approved drugs within 120 days) and sets up a 96-hour timeline for processing veterans' requests for nonformulary drugs. The VA must report annual formulary changes to Congress and implement a tiered copayment system that lowers costs for formulary drugs. The bill also includes provisions for negotiating drug discounts and value-based agreements to achieve cost savings.
HR 1909 reauthorizes federal funding and updates programs to reduce maternal deaths. It requires maternal mortality review committees to include obstetricians/gynecologists and improves death certificate reporting by coordinating with death certifiers. The bill mandates the CDC to share annual best practices for preventing maternal mortality with hospitals, state health groups, and perinatal programs. It also increases annual funding from $58 million to $100 million for these initiatives, covering fiscal years 2025 through 2029. The law directly affects hospitals, state health agencies, and maternal health programs receiving these federal funds.
Veterans' Assuring Critical Care Expansions to Support Servicemembers (ACCESS) Act of 2025 This bill addresses the administration of the Veterans Community Care Program (VCCP) and other Department of Veterans Affairs (VA) health care matters. Among other provisions regarding the VCCP, the bill establishes in statute access standards that determine when a veteran is eligible to receive non-VA care through the VCCP, requires the VA to notify veterans regarding their eligibility for care within two business days after the VA is aware the veteran is seeking care, and extends the deadline for the submittal of claims under the VCCP by health care entities and providers. The VA must address its mental health treatment programs by establishing a standardized screening process to determine whether a veteran satisfies criteria for priority or routine admission to a mental health residential rehabilitation treatment program or a program for residential care for mental health and substance abuse disorders, tracking the performance of medical facilities and Veterans Integrated Service Networks in meeting the requirements for mental health treatment screenings and timely admission to treatment programs under such screenings, and establishing an appeal process for when a veteran is denied admission to a covered treatment program or is accepted into a program but not offered bed placement in a timely manner. Additionally, the VA must establish an online self-service module for veterans to request and manage appointments, track referrals, and appeal and track decisions related to requests for care.
The HANDS Act (HR 5120) requires Medicare, Medicaid, and TRICARE to cover opioid overdose reversal drugs (such as naloxone) at no cost for patients at risk of opioid overdose who are being discharged from hospitals, emergency departments, or ambulatory surgical centers. Starting January 1, 2026, these drugs must be provided at the time of discharge along with administration instructions, eliminating all cost-sharing (like deductibles or copays) for eligible patients. The bill defines "preventive opioid overdose reversal drugs" as intranasal or intramuscular medications administered by healthcare providers (e.g., doctors or nurses) to at-risk patients during discharge. This policy aims to increase access to life-saving medication at critical care transition points without mandating provider administration.
This bill requires online contact lens sellers to provide a secure electronic method for customers to transmit their contact lens prescriptions, directly affecting online retailers. It mandates that such electronic transmissions comply with HIPAA privacy rules and that any protected health information sent via email must be encrypted. The law updates existing rules to modernize prescription verification for online sales while maintaining privacy protections.
Dentist and Optometric Care Access Act of 2025 or the DOC Access Act of 20 25 This bill prohibits private health insurance plans from setting rates for items and services, except for dental cleanings, provided by a doctor of optometry, of dental surgery, or of dental medicine (or an employer of such a doctor) for which the plan does not pay a substantial amount. Additionally, an agreement between a plan and such a doctor for limited scope dental or vision benefits may last longer than two years only with the prior acceptance of the doctor for each term extension. Plans also may not restrict such a doctor's choice of laboratories or suppliers. Such doctors may elect to waive the application of the payment amount and choice of laboratories provisions of this bill. The bill does not supersede state laws regarding health insurers and dental or vision benefit plans.
